Purchase Order 75F40126P00127

<p>The FDA's Office of Acquisition and Grants Services issued a purchase order to Sotax Corp on July 10, 2023, for an automated disintegration tester, with a ceiling value of $18,901.92. The order carries no set-aside designation. Performance occurs in Westborough, Massachusetts. The firm-fixed-price purchase order is for pharmaceutical testing equipment supporting FDA regulatory compliance and drug evaluation activities. Ultimate completion is scheduled for July 29, 2024.</p>

The Food and Drug Administration (FDA) awarded a $96,929.40 firm-fixed-price purchase order to Agilent Technologies Inc. to provide three dissolution apparatus systems with sampling units, temperature probes, vessels, and other accessories. The FDA's Division of Product Quality Research has a requirement for this specialized laboratory equipment. The contract has an ultimate completion date of May 14, 2022 and was awarded on April 13, 2021. This purchase order is not associated with a...

This is a $354,057.60 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Distek Inc., a small business manufacturer of laboratory equipment. The contract is for a SYMPHONY 7100 BATHLESS DISSOLUTION SYSTEM, which is used for dissolution testing. Distek has previously received other FDA contracts, both set-aside and unrestricted, for providing dissolution testing equipment and bioreactor controllers to the Department of Veterans Affairs. This award was not set...

The U.S. Food and Drug Administration (FDA) awarded a $76,915.84 firm-fixed-price purchase order to Sotax Corp, a manufacturer of pharmaceutical testing equipment, to provide a dissolution instrument with UV/Vis spectrometer and auto sampler. This equipment will be used by the FDA's Detroit Laboratory to conduct dissolution analysis on pharmaceutical medication samples, including from Department of Defense (DOD) and Veterans Administration (VA) stockpiles, to ensure acceptable dosing limits. The...

The Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Futuredrop Inc., a small business, on August 18, 2025, for a CERTUS FLEX laboratory dispenser system valued at $118,924.99. The award covers delivery and installation of the complete dispensing solution, including Windows-based control software, waste tray, well plate holder with manual insertion capability, accessories kit, two 0.2 millimeter microvalves without filter, air pressure regulator, starter kit, spare...

The Food and Drug Administration issued a purchase order to Electronic Risks Consultants, Inc., a small business, for post-warranty preventive maintenance and repair services on a Dionex Ultimate 3000 NCS-3500RS NANO UHPLC system interfaced with an ECLIPSE ORBITRAP ETD Mass Spectrometer, with a ceiling value of $237,252.00 and an award date of July 13, 2026. Performance occurs in Silver Spring, Maryland, with an ultimate completion date of July 12, 2029. The work supports the FDA's Center for...

<p>The Food and Drug Administration issued a $118,884 delivery order to Waters Technologies Corporation on June 4, 2024, for preventive maintenance of a Triple Quadrupole System/Ultra Performance Liquid Chromatography Mass Spectrometer (LC/MS/MS) system.</p> <p>The order is issued under the GSA Multiple Award Schedule (MAS). Place of performance is Milford, MA. The order is firm fixed price with an ultimate completion date of June 15, 2029. No set-aside was applied.</p>

<p>The Food and Drug Administration awarded a purchase order to Mitel Distributing Corp, a HUBZone-certified small business, for a dual dissolution bath with autosampler system valued at $152,224.60 on July 14, 2026. The equipment will be delivered to San Juan National Historic Site in San Juan, Puerto Rico, with ultimate completion by July 13, 2029. The contract carries firm fixed-price pricing.</p>

<p>The Food and Drug Administration issued a purchase order to Yokogawa Fluid Imaging Technologies, Inc. for a particle imaging analysis system on August 18, 2023, with a ceiling value of $100,309.00 and ultimate completion date of September 29, 2024. Work is performed in Newnan, Georgia. The order is firm fixed price with no set-aside designation.</p>

<p>The Food and Drug Administration issued a $6,632.29 delivery order to The Remi Group LLC on September 20, 2024, under the GSA Multiple Award Schedule for service agreement and maintenance on a Bio-Rad ddPCR system with automated droplet generator, plate sealer, and thermocycler.</p> <p>Place of performance is Silver Spring, MD. The order is priced on a firm fixed-price basis with an ultimate completion date of March 12, 2025. No set-aside was used.</p>